Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Gefitinib can cause scalp skin issues and permanent hair loss.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

Entospletinib effectively prevents eye and skin GVHD in mice.

Nilotinib can cause skin issues like red bumps and hair loss.

Burn injuries can cause long-term itching, skin color changes, and cancer risks, needing personalized treatment.

Low-dose radiation and certain drugs can inhibit keloid growth, revealing potential treatment targets.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

The Walleye dermal sarcoma virus cyclin causes excessive skin cell growth in mice.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

A new skin cancer can develop where shingles once occurred.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

c-Myc activation in mouse skin increases sebaceous gland growth and affects hair follicle development.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Many drugs, not just chemotherapy, can cause reversible hair loss.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

Microneedling for hair loss may cause skin cancer.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Noggin promotes skin tumors by activating Wnt and Shh pathways.